| INTRODUCTION
Grass pollen-related seasonal allergic rhinoconjunctivitis (SARg) affects millions of people worldwide with a noteworthy health 1 and economic burden. 2 Severity, comorbidities (eg, asthma, oral allergy syndrome-OAS), and response to pharmacotherapy and to allergen immunotherapy (AIT) can vary among patients. 3 The causes of this clinical heterogeneity are unknown and serological biomarkers of disease endotypes are currently missing. 4 The analysis of IgE sensitization at molecular level (so-called component-resolved diagnostics, CRD) disclosed a high heterogeneity of the molecular IgE sensitization profiles to grass pollen. 5 This observation might explain clinical diversity 6 and raise the hypothesis that IgE to individual molecules may serve as predictive biomarkers of specific clinical phenotypes and of disease evolution. 7, 8 In Europe, eight molecules of Phleum pratense, officially listed by the IUIS Allergen Nomenclature Sub-Committee, are frequently used in studies of grass pollen allergy. 9 They include grass-specific molecules, such as rPhl p 1, rPhl p 2, rPhl p 5, and rPhl p 6, and crossreactive molecules, such as nPhl p 4, rPhl p 7, rPhl p 11, and rPhl p 12. 10 Measurement of serum IgE to these molecules may be useful in the management of the grass pollen-allergic patient. 11 For example, detection of IgE to Phl p 1 may be sufficient to confirm grass pollen allergy in SAR 12 ; detection of IgE to Phl p 12 may predict OAS, 12, 13 and the simultaneous detection of IgE to Phl p 1, Phl p 5, and Phl p 12 may predict a higher risk of adverse reactions during AIT with grass extract. 14 We have previously shown that sensitization to P. pratense molecules starts with an IgE response to Phl p 1 in early childhood and later grows quantitatively and qualitatively by involving other grass molecules. 15 We also described that this "molecular spreading"
generates several different molecular IgE sensitization profiles, which may then influence the prescription of AIT. 16 The present study aims at describing the molecular profiles of IgE sensitization to Phleum pretense and testing the hypothesis that complex profiles or IgE sensitization to single molecules are useful to predict specific clinical phenotypes of SARg. To this end, we measured the concentration of serum IgE to the eight P. pratense molecules and assessed IgE complex sensitization profiles in a very large population of Italian children affected by SARg, whose clinical phenotype, severity, and comorbidities had been carefully diagnosed.
| MATERIALS AND METHODS

| Study design and population
The study population was enrolled in a large Italian nationwide In this analysis, we included only children with SPT to P. pratense ≥3 mm who were examined for sIgE to all eight P. pratense molecules.
| Questionnaire
Internationally validated questionnaires were administered to recruited children's parents: the International Study of Allergy and Asthma in Childhood, 18, 19 Allergic Rhinitis and its Impact on Asthma (ARIA) classification, 20 and the Global Initiative for Asthma (GINA). 21 Demographic data, history of atopic disease, occurrence of OAS, and triggering foods were also recorded. SAR was classified as intermittent or persistent, mild or moderate-severe according to the "ARIA classification". 20 An informatics platform ("AllergyCARD TM ", TPS Production, Rome, Italy) was used for data input. (holm), and Ambrosia artemisiifolia (ragweed). Histamine 0.1 mg/mL and glycerol solution were the positive and negative controls, respectively. Morrow-Brown needles were used to prick the skin.
| Skin prick tests
Readings were taken at 15 minutes, and a wheal ≥3 mm was regarded as positive.
| IgE assays
All the serum samples were tested for total IgE (tIgE) and specific beck, Germany), as previously described. 22 Results were expressed in kilounits per liter (kU A /L) and classified as positive or negative according to the cutoff level of 0.35. We additionally calculated the Phl p 1 "specific activity" (sIgE-tIgE ratio), as previously described. 23 Patients were categorized as "monomolecular," "oligomolecular,"
"polymolecular" in case of IgE recognition to 1, 2-4, or 5-8 molecules of P. pratense, respectively. The IgE sensitization profiles to the eight P. pratense molecules were defined according to the Allergen Profile Codification System (APCS), as previously reported. 22 
| Statistics
Data were summarized as numbers (n) and frequencies (%) if they were categorical and as mean and standard deviation (SD) if quantitative. The average concentration of tIgE and sIgE levels was calculated as geometric mean, and specifically for sIgE antibodies, only the positive serum samples were considered (see the above definition 3 | RESULTS
| Study population
The target population consisted in 1271 pediatric patients, recruited in the context of "PAN-PED" project. 24 The present study evaluated 1120 of these 1271 children, that is, those with a SPT-positive reaction to P. pratense extract (≥3 mm) and a complete dataset for sIgE to the eight P. pratense molecules (Fig. S1 ). We found no differences in male gender, familiar atopy, characteristics of SAR and OAS frequency between children included and excluded from the study (Table 1) . By contrast, older age, Northern Italian residency, higher atopic reactivity, and absence of asthma were more common among included patients than among those excluded (Table 1) . Among the 1120 patients included in the study population, we found that the cosensitization to other pollens represents a frequent event (eg, 69.1% of patients were sensitized to Olive tree, 40.8% to Cypress, and 38.9% to Birch) (Table S1 ).
| Molecular profiles of IgE to Phleum pratense
The analysis of IgE responses against eight P. pratense molecules in the 1120 participants showed a wide spectrum of 87 different sensitization profiles ( Figure 1A ). After exclusion of the "0" profile, the arbitrary threshold of 50% of the whole study population was covered by the eight most frequent profiles, defined by the APCS code as "128" (17.4%), "249" (6.3%), "216" (6.1%), "250" (5.2%),
"248" (5.1%), "251" (4.9%), "192" (4.8%), and "152" (3.6%) (Figure 1A ). These eight profiles were further examined in depth (see below). Overall, 233/1120 (22%) patients presented a "monomolecular" sensitization profile. Of these, only three (1%) were sensitized to Phl p 5, while 195 (84%) were sensitized to Phl p 1 ( Figure 1B ).
Moreover, 430/1120 (40%) were sensitized to 2-4 molecules ("oligomolecular") and 410/1120 (38%) were sensitized to >4 molecules 
| Characteristics of IgE sensitization
We analyzed the characteristics of atopic sensitization after stratification in relation to 3 different classifications of the IgE sensitization: (i) to each of the eight individual molecules; (ii) to each of the • Individual molecules -The 38/1120 (3%) patients sensitized to Phl p 7 had the highest levels of serum tIgE and of sIgE to the P. pratense extract or to other pollens, and the highest number of SPT-positive reactions to the panel of the examined pollen extracts (Table 2A) .
• IgE molecular sensitization profiles -The serum level of tIgE strongly increased in parallel with the complexity of the IgE sensitization profiles, ranging from 278 kU/L of the profile "128"
(monomolecular Phl p 1) to 803 kU/L of the profile "251" (seven IgE recognized molecules). A similar trend was followed by the levels of sIgE to the P. pratense extract (from 3.4 to 176 kU A /L) and to Phl p 1 (from 4.1 to 84 kU A /L) and by the overall sensitization to pollens extracts, expressed as number of positive SPT reactions or as sum of the serum sIgE antibodies (Table 2B ).
• Number of P. pratense molecules recognized by IgE -The serum levels of tIgE, of sIgE to P. pratense extract, and of sIgE to Phl p 1 and the number or overall degree of sensitization to pollen extracts were strongly related to the number of P. pratense molecules recognized by IgE (Figure 2 ). By contrast, the level of sIgE to Dermatophagoides pteronyssinus was inversely related to the number of P. pratense molecules recognized by IgE (P for trend F I G U R E 1 (A) Molecular profiles of IgE sensitization (≥0.35 KU A /L) to Phleum pratense molecules: rPhl p 1, rPhl p 2, rPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, rPhl p 12 in 1120 children with skin reaction to P. pratense (wheal ≥3 mm) and tested for sIgE to all considered molecules. The Allergen Profile Codification System (APCS) code, the number of children belonging to that specific code (n), the relative frequency (%), and the cumulative frequency (%) are shown. The profiles are ordered by decreasing frequency. (B) Prevalence of IgE response to P. pratense allergens, according to the molecular categories. "Monomolecular": IgE sensitization to 1 molecule only; "oligomolecular": 2-4 molecules; "polymolecular": 5-8 molecules.
<.001) (Fig. S3) . A multivariable linear regression analysis showed that the number of P. pratense molecules recognized by IgE had a negative effect on sIgE to Dermatophagoides pteronyssinus regardless of relevant confounder factors identified through univariate analysis (age, gender, tIgE, pollen not related AR, and pollen not related asthma) (Table S2 ).
| Clinical outcomes
Sensitizations to Phl p 7 and Phl p 12 were associated with a longer duration of SAR, while sensitization to Phl p 1 with a shorter duration (Table 3A) . Moreover, sensitization to Phl p 7 was significantly associated with a higher severity of SAR, with symptoms persisting for >4 mo/y and a higher prevalence of asthma. Finally, sensitization to Phl p 12 was associated with OAS (32.4%, P < .001) (Table 3A) . By contrast, a higher complexity of the APCS profile was directly associated with a longer duration of SAR only and it was inversely associated with symptoms persisting for >4 mo/y, but not to all the other clinical parameters (Table 3B ).
| DISCUSSION
We examined IgE sensitization to eight recombinant P. pratense allergenic molecules in the sera of 1120 children affected by grass Generalized estimating equation models taking into account multiple measures from the same subject, more precisely Phleum pratense index (a categorical variable indicating the specific-molecule sensitization for each subject) was included as independent variable: P values were adjusted for the number of Phleum pratense molecules recognized by sIgE (independent variable inserted in each model) and P values <0.05 are highlighted in bold. 
| Heterogeneity of the IgE sensitization profiles
Our molecular combinatorial analysis confirms that the qualitative homogeneity of IgE sensitization to the extract of P. pratense among grass pollen-allergic patients is only apparent. The number of described grass pollen IgE sensitization profiles, originally limited to 39, 22 is now expanded to 87, suggesting that, theoretically, all the 256 possible combinations could be observed if the study population was big enough. This high heterogeneity had been already confirmed among German 3 grass pollen-allergic patients. Our study adds that some profiles are much more frequent than others, so their clinical relevance can be investigated.
| Polymolecular sensitization predicts polysensitization to pollens but not to indoor allergens
Not surprisingly, the more complex profiles were characterized by a higher levels of tIgE and sIgE to P. pratense extract and by a longer history of SAR. These data confirm our previous observations in the MAS birth cohort 15, 25 and support the concept of the atopic march.
Moreover, a higher diversity of the IgE response to the individual molecules of P. pratense was strongly and linearly associated with both, a higher number and a higher degree of IgE sensitization to other pollens. Figure 2 shows for the first time that the polymolecular IgE sensitization profiles are strongly associated with pollen extract polysensitization. A strong propensity to atopic responses might underlie the molecular spreading of IgE responses not only to an individual allergen source (ie, P. pratense) but also to different allergen sources (ie, other pollens). However, we did not find any correlation between the number of P. pratense molecules recognized by IgE and the prevalence or intensity of the IgE response to cat and alternaria allergens. Surprisingly, the prevalence and the levels of IgE to Dermatophagoides pteronyssinus were even strongly and linearly inversely correlated to the number of P. pratense molecules recognized by IgE. This intriguing observation should be examined with caution, as we cannot exclude a selection bias due to our study inclusion criteria. Nevertheless, these data suggest that the molecular spreading process is characterized by a certain degree of "selectivity," whose nature and mechanisms should be better clarified in longitudinal studies. Our results suggest that sIgE to a few individual molecules of P. pratense can be used as diagnostic biomarkers:
• Phl p 1 -As already reported by previous studies, that the IgE sensitization to Phl p 1 is sufficient in most cases to corroborate a diagnosis of grass pollen allergy. 12, 30, 31 This conclusion may be of great relevance in diagnostic algorithms for grass pollen AIT.
• Phl p 7 -IgE sensitization to Phl p 7 (polcalcin) was relatively infrequent but strongly associated with asthma. During the IgE molecular spreading process, Phl p 7 is often the "last" molecule inducing an IgE response. 15 Accordingly, our 38 Phl p 7-sensitized children were highly polymolecularly sensitized and had high levels of serum tIgE and grass pollen sIgE. Therefore, the "asthma-biomarker" role of IgE to Phl p 7 is likely explained by a spurious association (Phl p 7 sensitization being a proxy of extreme polysensitization) rather than by a direct causal-effect link. Nevertheless, the data suggest that testing IgE for Phl p 7 may be useful not only to explain cross-reactivity, 32, 33 but also as a quite specific biomarker of asthma among SARg patients.
• Phl p 12 -IgE sensitization to Phl p 12 (profilin) was observed in over 25% of the examined patients and it was strongly associated with OAS. Our study therefore confirms that profilin is a known trigger of allergic reactions to plant-derived foods, mostly limited to the oral cavity. are normally rich in profilin, while only grass pollen extracts seem to contain also in polcalcin. 35 If this observation were confirmed, then grass pollen immunotherapy would be appropriated to induce a protective immune response to these two panallergens in polysensitized patients.
| Clinical relevance of IgE sensitization profiles
Our study population was big enough to test the hypothesis that molecular IgE sensitization profiles are of diagnostic value. The outcome of this analysis was rather frustrating, as no profile was associated with peculiar characteristic or with the severity of allergic disease. At least two facts may have contributed to this negative outcome. On the one hand, our study population is characterized by a very high prevalence of polysensitization to other pollens (birch, cypress, pellitory, olive tree, mugwort, plane tree) ( 20 did not allow a fine discrimination of symptoms severity. 38 Therefore, the clinical relevance of IgE sensitization profiles will have to be tested again in longitudinal studies, using a prospective registration of symptoms severity through symptoms-medication scores along a full pollen season. 39 Similarly, our study design did not address the question whether different IgE sensitization profiles predict efficacy 22 and adverse reactions 14, 40 to grass pollen immunotherapy.
| Limitations
We have to acknowledge additional study limitations. First, we tested sensitization to one grass pollen species only and the generalizability of our conclusions in settings and countries (eg, Australia 2 ) where P. pratense is less representative of the dominating grass pollen species may be questioned. Second, the relative frequency of IgE sensitization to P. pratense and other grass pollens in patients with SAR is higher in Northern than in Southern Italy.
17
Phleum pratense is the most relevant grass pollen allergen in Italy;
however, other grasses (eg, Bermuda grass, Lolium perenne) may play in patients a role in triggering seasonal allergic symptoms. 32 Third, the data on the SAR characteristics were based only on a retrospective questionnaire and, therefore, exposed to potential recall bias. Fourth, asthma and OAS could not be confirmed by lung tests and food challenge, respectively, and over-reporting cannot be excluded. Fifth, we examined a pediatric population; therefore, specific studies among adults should be performed to test whether the same conclusions could be applied to older groups.
However, a recent Italian study performed in 11 235 adult patients with AR showed percentages of IgE sensitization to P. pratense molecules comparable with our data. 41 
| CONCLUSION S
In conclusion, this nationwide study identifies 3 biomarkers in children population, Phl p 1, Phl p 7, and Phl p 12 that can be useful in the diagnostic workup of the child with grass pollen allergy. The study also shows an extreme heterogeneity of combinatorial molecular IgE sensitization profiles, whose clinical usefulness is limited to a Mediterranean country. Prospective studies in patient cohorts are now needed to expand our knowledge on the stability and predictive value of the observed associations.
ACKNOWLEDG MENTS
We thank ALK-Abell o and TFS for providing the reagents for the study, TPS Production for the informatics platform AllergyCARD. 
CONFLI CTS OF INTEREST
